학술논문

Reducing mortality and morbidity in patients with severe COVID-19 disease by advancing ongoing trials of Mesenchymal Stromal (stem) Cell (MSC) therapy — Achieving global consensus and visibility for cellular host-directed therapies
Document Type
Editorial
Source
In International Journal of Infectious Diseases July 2020 96:431-439
Subject
Language
ISSN
1201-9712